# Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients

> **NCT01453257** · PHASE2 · COMPLETED · sponsor: **Grupo Hospital de Madrid** · enrollment: 72 (actual)

## Conditions studied

- Progression Free Survival

## Interventions

- **DRUG:** Tailored Chemotherapy

## Key facts

- **NCT ID:** NCT01453257
- **Lead sponsor:** Grupo Hospital de Madrid
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2011-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01453257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01453257, "Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01453257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*